Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩92,900.00
Year range
₩72,600.00 - ₩130,000.00
Market cap
7.28T KRW
Avg Volume
195.58K
P/E ratio
28.96
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 144.38B | 26.67% |
Operating expense | 108.21B | 17.96% |
Net income | 23.30B | 81.61% |
Net profit margin | 16.14 | 43.34% |
Earnings per share | — | — |
EBITDA | 30.30B | 106.67% |
Effective tax rate | 3.51% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 268.69B | -7.68% |
Total assets | 1.00T | 26.60% |
Total liabilities | 410.56B | -9.05% |
Total equity | 591.47B | — |
Shares outstanding | 78.31M | — |
Price to book | 12.82 | — |
Return on assets | 6.30% | — |
Return on capital | 8.70% | — |
Cash Flow
Net change in cash
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 23.30B | 81.61% |
Cash from operations | 27.29B | 21.71% |
Cash from investing | -1.51B | -152.86% |
Cash from financing | -76.72B | -423.96% |
Net change in cash | -55.86B | -212.15% |
Free cash flow | 16.62B | 66.03% |
About
Founded
1993
Website
